People: Greenway Medical Technologies Inc (GWAY.N)
GWAY.N on New York Stock Exchange
11.47USD
3:55pm EDT
11.47USD
3:55pm EDT
Price Change (% chg)
$-0.28 (-2.38%)
$-0.28 (-2.38%)
Prev Close
$11.75
$11.75
Open
$11.71
$11.71
Day's High
$11.87
$11.87
Day's Low
$11.33
$11.33
Volume
7,942
7,942
Avg. Vol
24,355
24,355
52-wk High
$19.60
$19.60
52-wk Low
$11.08
$11.08
Summary
| Name | Age | Since | Current Position |
|---|---|---|---|
W. Thomas Green |
68 | 2010 | Chairman of the Board |
Wyche Green |
40 | 2010 | President, Chief Executive Officer, Director |
James Cochran |
65 | 2009 | Chief Financial Officer |
Gregory Schulenburg |
47 | 2004 | Chief Operating Officer, Executive Vice President |
William Esslinger |
41 | 2004 | Vice President, General Counsel, Secretary |
Robert Hensley |
55 | 2011 | Independent Director |
D. Neal Morrison |
51 | 2006 | Independent Director |
Thomas Richards |
71 | 1998 | Independent Director |
Walter Turek |
60 | 2005 | Independent Director |
Noah Walley |
49 | 2004 | Independent Director |
Biographies
| Name | Description |
|---|---|
W. Thomas Green |
Mr. W. Thomas Green, Jr., serves as Chairman of the Board of Greenway Medical Technologies, Inc. From 1998 until 2010, he also served as Chief Executive Officer. From 2006 to 2010, Mr. Green was a director of the First National Bank of Georgia and WGNB Corporation in Carrollton, Georgia. Mr. Green is the past Chairman of the Tanner Medical Foundation. Mr. Green also formerly served as a board member and executive committee member of the State University of West Georgia Foundation. Mr. Green received a bachelor’s degree in business administration from the University of Georgia. |
Wyche Green |
Mr. Wyche T. Green, III, serves as President, Chief Executive Officer, Director of Greenway Medical Technologies, Inc. He has served as the Company’s President since 2000, as Chief Executive Officer since 2010, and has been a Director of the Company since 1999. Mr. Green is responsible for the Company’s strategic direction while managing day-to-day operations. Mr. Green first joined the Company in September 1999 as Vice-President of Sales and Marketing, working in that capacity one year before being promoted to President. From 2003 until May 2011, Mr. Green was a member of the board of directors of First Georgia Banking Company. Mr. Green also serves on the Auburn University Research Council Board. Mr. Green received a bachelor’s degree in business administration management from Auburn University. |
James Cochran |
Mr. James A. Cochran is Chief Financial Officer of Greenway Medical Technologies, Inc. He oversees the Company’s financial reporting, accounting and internal control, and strategic planning. From February 2009 to October 2009, Mr. Cochran was pursuing personal interests. From October 2007 until its sale in January 2009, Mr. Cochran served as Senior Vice President, Corporate Strategy and Investor Relations of TurboChef Technologies, Inc. (“TurboChef”), a manufacturer of speed-cook commercial and residential ovens. In October 2003 Mr. Cochran joined TurboChef as Senior Vice President and Chief Financial Officer and served in that capacity until October 2007. From its formation in August 2000 until its acquisition by the Eastman Kodak Company in October 2003, Mr. Cochran served as Chief Financial Officer of PracticeWorks, Inc., then a publicly traded software company specializing in dental practice management. Mr. Cochran is a Certified Public Accountant and was a partner of the accounting firm BDO Seidman, LLP for five years. Mr. Cochran received a B.B.A. in Accounting and an M.B.A. in Corporate Finance from Georgia State University. |
Gregory Schulenburg |
Mr. Gregory H. Schulenburg is Chief Operating Officer, Executive Vice President of Greenway Medical Technologies, Inc., since May 2004. Mr. Schulenburg oversees and manages the day-to-day operations of the Company. From joining the Company in March 1999 until May 2004, he served as Vice President of Research and Development, managing software development for the Company. Mr. Schulenburg received a bachelor’s degree in economics from the University of Georgia. |
William Esslinger |
Mr. William G. Esslinger, Jr., is Vice President, General Counsel, Secretary of Greenway Medical Technologies, Inc. Mr. Esslinger oversees all ongoing activities related to policies and procedures covering the privacy of and access to patient health information in compliance with federal and state laws, including HIPAA. By marriage, Mr. Esslinger is a first cousin of Wyche T. Green, III. Mr. Esslinger is a member of the State Bar of Georgia. Mr. Esslinger is also a member of the American Corporate Counsel Association, and a member of the International Association of Privacy Professionals. Prior to joining Greenway, Mr. Esslinger was in the private practice of law. Mr. Esslinger earned his bachelor’s degree in finance from the State University of West Georgia and his juris doctorate from the Georgia State University College of Law. |
Robert Hensley |
Mr. Robert Z. Hensley serves as Independent Director of Greenway Medical Technologies, Inc. He is currently a senior advisor to the transaction advisory services group of Alvarez & Marsal, LLC, a global professional services firm. From 2002 to 2003, he was an audit partner in the Nashville office of Ernst & Young LLP, a global professional services firm. From 1990 to 2002, Mr. Hensley served as an audit partner and, from 1997 to 2002, as office managing partner, of the Nashville office of Arthur Andersen LLP, an accounting firm. Mr. Hensley also serves, or has served within the last five years, on the boards of directors of COMSYS IT Partners, Inc., Advocat, Inc., Spheris, Inc., HealthSpring, Inc., Document Technologies Inc., Insight Global, Inc. and Capella Healthcare, Inc. |
D. Neal Morrison |
Mr. D. Neal Morrison is Independent Director of Greenway Medical Technologies, Inc., since October 2006. Since January 2012, Mr. Morrison has been a Senior Advisor of Pamlico Capital (formerly Wachovia Capital Partners and previously First Union Capital Partners), a private equity firm focused on investments in growth-oriented healthcare, business and technology services and communications companies. Mr. Morrison focuses on making investments in the healthcare industry. Prior to serving as Senior Advisor, Mr. Morrison had been a Partner of Pamlico Capital since 1996. Prior to joining First Union Capital Partners, Mr. Morrison served as a director of First Union’s Healthcare Finance Group since 1987. Mr. Morrison was a director of US Radiosurgery LLC from 2003 to 2011, a director of American Renal Holdings, Inc. from 2004 to 2010, a director of A4 Health Systems, Inc. from 1999 to 2005, a director of excelleRx, Inc. from 2003 to 2005 and a director of Acist Medical Systems, Inc. from 2000 to 2001. Mr. Morrison received his undergraduate degree from the University of North Carolina at Chapel Hill in 1984 and his graduate degree from the Babcock Graduate School of Management at Wake Forest University in 1987. |
Thomas Richards |
Mr. Thomas T. Richards serves as Independent Director of Greenway Medical Technologies, Inc. He is a member of the Audit Committee and the Nominations and Governance Committee. Mr. Richards has also been president and owner of Richards Mortgage Servicing, Inc., a financial service company that owns and services single family mortgages, since 1996. From 1984 until 2010, Mr. Richards was a director of First National Bank of Georgia and WGNB Corporation. Mr. Richards is a board member of Tanner Medical Foundation. Mr. Richards is a graduate of the Georgia Institute of Technology and Harvard Business School. |
Walter Turek |
Mr. Walter Turek serves as Independent Director of Greenway Medical Technologies, Inc. He is a member of the Compensation Committee and Chairman of the Nominations and Governance Committee. Since December 2011, he has served as executive chairman of Ascentis, a human capital management firm headquartered in Bellevue, Washington. In 2009, Mr. Turek co-founded and served as director of Mykonos Software, a security software company, until it was sold to Juniper Networks in February 2012. From 1981-2009, Mr. Turek held various positions in Paychex, Inc. (“Paychex”), a national provider of payroll and human resource services. From 1991 until 2002, Mr. Turek was vice president of sales and marketing and, from 2002 until his retirement in June 2009, Mr. Turek was senior vice president of sales and marketing for Paychex. In this role, Mr. Turek was responsible for an organization of 2,500 employees both domestic and international. In addition, prior to his retirement in June 2009, Mr. Turek served as president of Stromberg, a provider of time and labor solutions, and president of Rapid Payroll, Inc., a California-based payroll software company. Both companies were wholly-owned subsidiaries of Paychex. Mr. Turek has served on the board of trustees of Nazareth College and currently is on the board of directors of BlueTie.com and Adventive Software, each of which is a private company. Mr. Turek attended Rochester Institute of Technology and received his associate's degree from Monroe Community College. |
Noah Walley |
Mr. Noah J. Walley is Independent Director of Greenway Medical Technologies, Inc., since May 2004. Since April 2003, Mr. Walley has served as Head of North American Technology Investing of Investor Growth Capital, Inc., a venture capital firm. Prior to his tenure at Investor Growth Capital, Mr. Walley served as a General Partner with Morgan Stanley Venture Partners and, prior to joining Morgan Stanley, he worked for the venture capital firms of Bachow & Associates and Desai Capital Management, as well as the management consulting firm McKinsey & Company. Mr. Walley began his investment banking career in London for Chase Manhattan Bank and NM Rothschild & Sons, Ltd. Mr. Walley also serves on the board of directors of Tangoe, Inc., a provider of communications lifecycle management software and services to a wide range of enterprises. Mr. Walley holds a J.D. degree from Stanford Law School and as well as M.A. and B.A. degrees from Oxford University. |
Basic Compensation
| Name | Fiscal Year Total |
|---|---|
W. Thomas Green |
1,081,170 |
Wyche Green |
1,785,670 |
James Cochran |
842,917 |
Gregory Schulenburg |
964,854 |
William Esslinger |
686,455 |
Robert Hensley |
-- |
D. Neal Morrison |
-- |
Thomas Richards |
-- |
Walter Turek |
-- |
Noah Walley |
-- |
As Of 29 Jun 2012
Options Compensation
| Name | Options | Value |
|---|---|---|
W. Thomas Green |
0 | 0 |
Wyche Green |
0 | 0 |
James Cochran |
0 | 0 |
Gregory Schulenburg |
1,780 | 15,531 |
William Esslinger |
814 | 7,655 |
Robert Hensley |
0 | 0 |
D. Neal Morrison |
0 | 0 |
Thomas Richards |
0 | 0 |
Walter Turek |
0 | 0 |
Noah Walley |
0 | 0 |
| Name | Shares Traded | Price |
|---|---|---|
TUREK WALTER LEON |
4,400 | $12.98 |
TUREK WALTER LEON |
5,600 | $12.64 |
GREEN WYCHE T JR |
3,800 | $16.27 |
COCHRAN JAMES A |
10,000 | $15.30 |
COCHRAN JAMES A |
10,000 | $5.19 |
HENSLEY ROBERT Z |
2,000 | $14.93 |
ESSLINGER WILLIAM G JR |
1,060 | $4.75 |
ESSLINGER WILLIAM G JR |
516 | $4.75 |
COCHRAN JAMES A |
10,000 | $5.19 |
SCHULENBURG GREGORY H |
775 | $4.75 |
SCHULENBURG GREGORY H |
2,400 | $4.75 |
GREEN WYCHE T JR |
353 | $0.00 |
GREEN WYCHE T JR |
353 | $0.00 |
GREEN WYCHE T JR |
1,200 | $0.00 |
GREEN WYCHE T JR |
1,500 | $18.05 |
GREEN WYCHE T JR |
6,600 | $18.00 |
COCHRAN JAMES A |
10,000 | $19.39 |
HENSLEY ROBERT Z |
3,000 | $16.18 |
COCHRAN JAMES A |
15,000 | $16.52 |
COCHRAN JAMES A |
15,000 | $5.19 |
GREEN WYCHE T JR |
14,000 | $0.00 |
GREEN WYCHE T JR |
14,000 | $0.00 |
COCHRAN JAMES A |
20,000 | $5.19 |
RICHARDS THOMAS T |
90,586 | $6.00 |
COCHRAN JAMES A |
10,000 | $5.19 |
Thomson Reuters is the world's largest international multimedia news agency, providing investing news, world news, business news, technology news, headline news, small business news, news alerts, personal finance, stock market, and mutual funds information available on Reuters.com, video, mobile, and interactive television platforms. Thomson Reuters journalists are subject to an Editorial Handbook which requires fair presentation and disclosure of relevant interests.
NYSE and AMEX quotes delayed by at least 20 minutes. Nasdaq delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
